{
    "Trade/Device Name(s)": [
        "Bioland G-425-2V Blood Glucose Monitoring System",
        "Bioland G-425-2 Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Bioland Technology Ltd.",
    "510(k) Number": "K202739",
    "Predicate Device Reference 510(k) Number(s)": [
        "K191657"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "August 12, 2022",
    "Summary Letter Received Date": "May 16, 2022",
    "Submission Date": "May 16, 2022",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood (fingertip)"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "Bioland G-425-2V Blood Glucose Meter",
        "Bioland G-425-2 Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric glucose biosensor"
    ],
    "Methodologies": [
        ""
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for Bioland G-425-2V and G-425-2 blood glucose monitoring systems for home use in diabetes monitoring without Bluetooth connectivity",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood from fingertip; self-testing by people with diabetes at home to monitor effectiveness of diabetes control; not for diagnosis, screening, or use in neonates",
    "fda_folder": "Clinical Chemistry"
}